 |
|
|
| |
MASS BALANCE, METABOLIC PROFILE, AND THE ROLE OF HEPATIC AND BACTERIAL ENZYMES IN THE METABOLISM OF THE HCV POLYMERASE INHIBITOR, DELEOBUVIR
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
R Sane1, L-Z Chen1, E Philip1, S Regan1, H Maw1, H Yu1, A Mathur1, Y Li1, DA Mandarino2, JP Sabo11Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 2Covance Clinical Research Unit Inc., Madison, WI, USA
Rucha Sane rucha.sane@boehringer-ingelheim.com
|
| |
|
|
|
|
|
